Perforin and lymphohistiocytic proliferative disorders

British Journal of Haematology

Volumn 128, Issue 6, 2005, Pages 739-750

  Katano, Harutaka ^a   Cohen, Jeffrey I ^b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Epstein Barr virus; Familial haemophagocytic lymphohistiocytosis; Haemophagocytosis; Histiocytosis; Perforin

Indexed keywords

CYTOKINE; PERFORIN;

CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEVER; GENE MUTATION; GENE THERAPY; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOSPLENOMEGALY; HUMAN; INFECTION CONTROL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCYTOPENIA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TH1 CELL; TH2 CELL; VIRUS MENINGITIS;

ADULT; ANIMALS; CELL PROLIFERATION; CHILD; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; KILLER CELLS, NATURAL; LINKAGE (GENETICS); MEMBRANE GLYCOPROTEINS; MICE; MUTATION; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 15944399347     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05305.x     Document Type: Review

References (112)

1. Akashi, K., Hayashi, S., Gondo, H., Mizuno, S., Harada, M., Tamura, K., Yamasaki, K., Shibuya, T., Uike, N., Okamura, T., Miyamoto, T. & Niho, Y. (1994) Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. British Journal of Haematology, 87, 243-250.
2. Andersson, J., Behbahani, H., Lieberman, J., Connick, E., Landay, A., Patterson, B., Sonnerborg, A., Lore, K., Uccini, S. & Fehniger, T.E. (1999) Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS, 13, 1295-1303.
3. Appay, V., Nixon, D.F., Donahoe, S.M., Gillespie, G.M., Dong, T., King, A., Ogg, G.S., Spiegel, H.M., Conlon, C., Spina, C.A., Havlir, D.V., Richman, D.D., Waters, A., Easterbrook, P., McMichael, A.J. & Rowland-Jones, S.L. (2000) HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. Journal of Experimental Medicine, 192, 63-75.
4. Arico, M., Janka, G., Fischer, A., Henter, J.I., Blanche, S., Blinder, G., Martinetti, M. & Rusca, M.P. for the FHL Study Group of the Histiocyte Society (1996) Haemophagocytic lymphohistiocytosis: report of 122 children from the International Registry. Leukemia, 10, 197-203.
5. Arico, M., Allen, M., Brusa, S., Clementi, R., Pende, D., Maccario, R., Moretta, L. & Danesino, C. (2002) Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perform expression. British Journal of Haematology, 119, 180-188.
6. Arnaout, R.A. (2000) Perforin deficiency: fighting unarmed? Immunology Today, 21, 52.
7. Badovinac, V.P., Tvinnereim, A.R. & Harty, J.T. (2000) Regulation of antigen-specific CD8+ T cell homeostasis by perform and interferon-gamma. Science, 290, 1354-1358.
8. Badovinac, V.P., Hamilton, S.E. & Harty, J.T. (2003) Viral infection results in massive CD8+ T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity, 18, 463-474.
9. Baetz, A., Isaaz, S. & Griffiths, G.M. (1995) Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arise from a secretory defect that prevents lytic granule exoctyosis. Journal of Immunology, 154, 6122-6131.
10. Balaji, K.N., Schaschke, N., Machleidt, W., Catalfamo, M. & Henkart, P.A. (2002) Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation. Journal of Experimental Medicine, 196, 493-503.
11. Barbosa, M.D., Nguyen, Q.A., Tchernev, V.T., Ashley, J.A., Detter, J.C., Blaydes, S.M., Brandt, S.J., Chotai, D., Hodgman, C., Solari, R.C., Lovett, M. & Kingsmore, S.F. (1996) Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature, 382, 262-265.
12. Barry, M., Heibein, J.A., Pinkoski, M.J., Lee, S.F., Moyer, R.W., Green, D.R. & Bleackley, R.C. (2000) Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Molecular and Cellular Biology, 20, 3781-3794.
13. Binder, D., van den Broek, M.F., Kagi, D., Bluethmann, H., Fehr, J., Hengartner, H. & Zinkernagel, R.M. (1998) Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus. Journal of Experimental Medicine, 187, 1903-1920.
14. Biron, C.A., Pedersen, K.F. & Welsh, R.M. (1987) Aberrant T cells in beige mutant mice. Journal of Immunology, 138, 2050-2056.
15. van den Broek, M.F., Kagi, D., Zinkernagel, R.M. & Hengartner, H. (1995) Perforin dependence of natural killer cell-mediated tumor control in vivo. European Journal of Immunology, 25, 3514-3516.
16. Browne, K.A., Blink, E., Sutton, V.R., Froelich, C.J., Jans, D.A. & Trapani, J.A. (1999) Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin. Molecular and Cellular Biology, 19, 8604-8615.
17. Busiello, R., Adriani, M., Locatelli, F., Galgani, M., Fimiani, G., dementi, R., Ursini, M.V., Racioppi, L. & Pignata, C. (2004) Atypical features of familial hemophagocytic lymphohistiocytosis. Blood, 103, 4610-4612.
18. Clementi, R., zur Stadt, U., Savoldi, G., Varotto, S., Conter, V., De Fusco, C., Notarangelo, L.D., Schnedier, M., Klersy, C., Janka, G., Danesino, C. & Arico, M. (2001) Six novel mutations in the PRF1 gene in children with haemophagocytic lymphohistiocytosis. Journal of Medical Genetics, 38, 643-646.
19. Clementi, R., Emmi, L., Maccario, R., Liotta, F., Moretta, L., Danesino, C. & Arico, M. (2002) Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood, 100, 2266-2267.
20. Coffey, A.J., Brooksbank, R.A., Brandau, O., Oohashi, T., Howell, G.R., Bye, J.M., Cahn, A.P., Durham, J., Heath, P., Wray, P., Pavitt, R., Wilkinson, J., Leversha, M., Huckle, E., Shaw-Smith, C.J., Dunham, A., Rhodes, S., Shuster, V., Porta, G., Yin, L., Serafini, P., Sylla, B., Zollo, M., Franco, B., Bolino, A., Seri, M., Lanyi, A., Davis, J.R., Webster, D., Harris, A., Lenior, G., de St. Basile, G., Jones, A., Behloradsky, B.H., Achatz, H., Nurken, J., Fassler, R., Sumegi, J., Romeo, G., Vaudin, M., Ross, M.T., Meindl, A. & Bentley, D.R. (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genetics, 20, 129-135.
21. Crotty, S., Kersh, E.N., Cannons, J., Schwartzberg, P.L. & Ahmed, R. (2003) SAP is required for generating long-term humoral immunity. Nature, 421, 282-287.
22. Czar, M.J., Kersh, E.N., Mijares, L.A., Lanier, G., Lewis, J., Yap, G., Chen, A., Sher, A., Duckett, C.S., Ahmed, R. & Schwartzberg, P.L. (2001) Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proceedings of the National Academy of Sciences of the United States of America, 98, 7449-7454.
23. Darmon, A.J., Nicholson, D.W. & Bleackley, R.C. (1995) Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature, 377, 446-448.
24. Denkers, E.Y., Yap, G., Scharton-Kersten, T., Charest, H., Butcher, B.A., Caspar, P., Heiny, S. & Sher, A. (1997) Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. Journal of Immunology, 159, 1903-1908.
25. Fadeel, B., Orrenius, S. & Henter, J.I. (1999) Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients. British Journal of Haematology, 106, 406-415.
26. Feldmann, J., Le Deist, F., Ouachee-Chardin, M., Certain, S., Alexander, S., Quartier, P., Haddad, E., Wulffraat, N., Casanova, J.L., Blanche, S., Fischer, A. & de Saint Basile, G. (2002) Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. British Journal of Haematology, 117, 956-972.
27. Feldmann, J., Callebaut, I., Raposo, G., Certain, S., Bacq, D., Dumont, C., Lambert, N., Ouachee-Chardin, M., Chedeville, G., Tamary, H., Minard-Colin, V., Vilmer, E., Blanche, S., Le Deist, F., Fischer, A. & de Saint Basile, G. (2003) Muncl3-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell, 115, 461-473.
28. Franco, M.A., Tin, C., Rott, L.S., van Cott, J.L., McGhee, J.R. & Greenberg, H.B. (1997) Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, Fas, and gamma-interferon. Journal of Virology, 71, 479-486.
29. Froelich, C.J., Orth, K., Turbov, J., Seth, P., Gottlieb, R., Babior, B., Shah, G.M., Bleackley, R.C., Dixit, V.M. & Hanna, W. (1996) New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. Journal of Biological Chemistry, 271, 29073-29079.
30. Gebhard, J.R., Perry, C.M., Harkins, S., Lane, T., Mena, I., Asenio, V.C., Campbell, I.L. & Whitton, J.L. (1998) Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. American Journal of Pathology, 153, 417-428.
31. Ghiasi, H., Cai, S., Perng, G-C., Nesburn, A.B. & Wechsler, S.L. (1999) Perforin pathway is essential for protection of mice against lethal ocular HSV-1 challenge but not corneal scarring. Virus Research, 65, 97-101.
32. Goransdotter Ericson, K., Fadeel, B., Nilsson-Ardnor, S., Soderhall, C., Samuelsson, A., Janka, G., Schneider, M., Gurgey, A., Yalman, N., Revesz, T., Egeler, R., Jahnukainen, K., Storm-Mathiesen, I., Haraldsson, A., Poole, J., de Saint Basile, G., Nordenskjold, M. & Henter, J. (2001) Spectrum of perforin gene muations in familial hemophagocytic lymphohistiocytosis. American Journal of Human Genetics, 68, 590-597.
33. Graubert, T.A., DiPersio, J.F., Russell, J.H. & Ley, T.J. (1997) Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. Journal of Clinical Investigation, 100, 904-911.
34. Haddad, E.K., Wu, X., Hammer, Jr, J.A. & Henkart, P.A. (2001) Defective granule exocytosis in Rab27a-deficient lymphocytes from ashen mice. Journal of Cell Biology, 152, 835-842.
35. Henkart, P.A. (2000) Overview of cytotoxic lymphocyte effector mechanisms. In: Cytotoxic Cells: Basic Mechanisms (ed. by Sitkovsky, M. & P.A. Henkart), pp. 111-145. Lippincott, Williams & Wilkins, Philadelphia, PA.
36. Henkart, P.A., Williams, M.S., Zacharchuk, C.M. & Sarin, A. (1997) Do CTL kill target cells by inducing apoptosis? Seminars in Immunology, 9, 135-144.
37. Henter, J.I., Ekinder, G., Soder, O., Hansson, M., Andersson, B. & Andersson, U. (1991a) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood, 78, 2918-2922.
38. Henter, J.I., Carlson, L.A., Soder, O., Nilsson-Ehle, P. & Blinder, G. (1991b) Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis. Acta Pediatrica Scandinavica, 80, 675-681.
39. Henter, J.I., Elinder, G., Ost, A. & the FHL Study Group of the Histiocyte Society (1991c) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Seminars in Oncology, 18, 29-33.
40. Henter, J.I., Arico, M., Elinder, G., Imashuku, S. & Janka, G. (1998) Familial hemophagocytic lymphohistiocytosis. Hematology/Oncology Clinics of North America, 12, 417-433.
41. Hoang, M.P., Dawson, B., Rogers, Z.R., Scheuermann, R.H. & Rogers, B.B. (1998) Polymerase chain reaction amplification of archival material for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, and parvovirus B19 in children with bone marrow hemophagocytosis. Human Pathology, 29, 1074-1077.
42. Imashuku, S. (2002) Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Critical Reviews in Oncology/Hematology, 44, 259-272.
43. Janka, G.E. & Schneider, E.M. (2004) Modern management of children with haemophagocytic lymphohistiocytosis. British Journal of Haematology, 124, 4-14.
44. Janka, G., Imashuku, S., Elinder, G., Schneider, M. & Henter, J.I. (1998) Infection- and malignancy-associated hemophagocytic syndromes: secondary hemophagocytic lymphohistiocytosis. Hematology/Oncology Clinics of North America, 12, 435-444.
45. Jiang, Z., Podack, E. & Levy, R.B. (2001) Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4+ donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis. Blood, 98, 390-397.
46. Jordan, M.B., Hildeman, D., Kappler, J. & Marrack, P. (2004) An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood, 104, 735-743.
47. Kagi, D., Ledermann, B., Burkl, K., Seiler, P., Odermatt, B., Olsen, K.J., Podack, E.R., Zinkernagel, R.M. & Hengartner, H. (1994a) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature, 369, 31-37.
48. Kagi, D., Ledermann, B., Burki, K., Hengartner, H. & Zinkernagel, R.M. (1994b) CD8+ T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. European Journal of Immunology, 24, 3068-3072.
49. Kagi, D., Seiler, P., Pavlovic, J., Ledermann, B., Burki, K., Zinkernagel, R.M. & Hengartner, H. (1995) The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and non-cytopathic viruses. European Journal of Immunology, 25, 3256-3262.
50. Kagi, D., Odermatt, B. & Mak, T.W. (1999) Homeostatic regulation of CD8+ T cells by perforin. European Journal of Immunology, 29, 3262-3272.
51. Katano, H., Ali, M.A., Patera, A.C., Catalfamo, M., Jaffe, E.S., Kimura, H., Dale, J.K., Straus, S.E. & Cohen, J.I. (2004) Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood, 103, 1244-1252.
52. Kawaguchi, H., Miyashita, T., Herbst, H., Niedobitek, G., Asada, M., Tsuchida, M., Hanada, R., Kinoshita, A., Sakurai, M., Kobauashi, N. & Mizutami, S. (1993) Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. Journal of Clinical Investigation, 92, 1444-1450.
53. Khanolkar, A., Yagita, H. & Cannon, M.J. (2001) Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells. Virology, 287, 79-88.
54. Kimura, H., Hoshino, Y., Kanegane, H., Tsuge, I., Okamura, T., Kawa, K. & Morishima, T. (2001) Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood, 98, 280-286.
55. Kogawa, K., Lee, S.M., Villanueva, J., Marmer, D., Sumegi, J. & Filipovich, A.H. (2002) Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistocytosis and their family members. Blood, 99, 61-66.
56. Kojima, H., Shinohara, N., Hanaoka, S., Someya-Shirota, Y., Takagaki, Y., Ohno, H., Saito, T., Katayama, T., Yagita, H., Okumura, K., Shinkai, Y., Alt, F.W., Matsuzawa, A., Yonehara, S. & Takayama, H. (1994) Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity, 1, 357-364.
57. Komp, D.M., McNamara, J. & Buckley, P. (1989) Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood, 73, 2128.
58. Latour, S., Gish, G., Helgason, C.D., Humphries, R.K., Pawson, T. & Veillette, A. (2001) Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nature Immunology, 2, 681-690.
59. Lichtenheld, M.G., Olsen, K.J., Lu, P., Lowrey, D.M., Hameed, A., Hengartner, H. & Podack, E.R. (1988) Structure and function of human perforin. Nature, 335, 448-451.
60. Lieberman, J. (2003) The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nature Reviews in Immunology, 3, 361-370.
61. Lowin, B., Peitsch, M.C. & Tschopp, J. (1995) Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Current Topics in Microbiology and Immunology, 198, 1-24.
62. Ma, X., Okamura, A., Yosioka, M., Ishiguro, N., Kikuta, H. & Kobayashi, K. (2001) No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan. Journal of Medical Virology, 65, 358-361.
63. Malipiero, U., Frei, K., Spanaus, K.S., Agresti, C., Lassman, H., Hahne, M., Tschopp, J., Eugster, H.P. & Fontana, A. (1997) Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. European Journal of Immunology, 27, 3151-3160.
64. Martin, P.J., Akatsuka, Y., Hahne, M. & Sale, G. (1998) Involvement of donor T-cell cytotoxic effector mechanisms in preventing allogeneic marrow graft rejection. Blood, 92, 2177-2181.
65. Masson, D., Peters, P.J., Geuze, H.J., Borst, J. & Tschopp, J. (1990) Interaction of chondroitin sulfate with perforin and granzymes of cytolytic T-cells is dependent on pH. Biochemistry, 29, 11229-11235.
66. Matloubian, M., Suresh, M., Glass, A., Galvan, M., Chow, K., Whitmore, J.K., Walsh, C.M., Clark, W.R. & Ahmed, R. (1999) A role for perforin in downregulating T-cell responses during chronic viral infection. Journal of Virology, 73, 2527-2536.
67. Menasche, G., Pastural, E., Feldmann, J., Certain, S., Ersoy, F., Dupuis, S., Wulffraat, N., Bianchi, D., Fischer, A., Le Deist, F. & de Saint Basile, G. (2000) Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nature Genetics, 25, 173-176.
68. Metkar, S.S., Wang, B., Aguilar-Santelises, M., Raja, S.M., Uhlin-Hansen, L., Podack, E., Trapani, J.A. & Froelich, C.J. (2002) Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity, 16, 417-428.
69. Migueles, S.A., Laborico, A.C., Shupert, W.L., Sabbaghian, M.S., Rabin, R., Hallahan, C.W., Van Baarle, D., Kostense, S., Miedema, F., McLaughlin, M., Ehler, L., Metcalf, J., Liu, S. & Connors, M. (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nature Immunology, 3, 1061-1068.
70. Molleran Lee, S., Villanueva, J., Sumegi, J., Zhang, K., Kogawa, K., Davis, J. & Filipovich, A.H. (2004) Characterisation of diverse PRF1 mutations leading to decreased killer cell activity in North American families with haemophagocytic lymphohistiocytosis. Journal of Medical Genetics, 41, 137-144.
71. Moretta, L., Moretta, A., Hengartner, H. & Zinkernagel, R.M. (2000) On the pathogenesis of perforin defects and related immunodeficiencies. Immunology Today, 21, 593-594.
72. Mullbacher, A., Hla, R.T., Museteanu, C. & Simon, M.M. (1999) Perform is essential for control of ectromelia virus but not related poxviruses in mice. Journal of Virology, 73, 1665-1667.
73. Nagle, D.L., Karim, M.A., Woolf, E.A., Holmgren, L., Bork, P., Misumi, D.J., McGrail, S.H., Dussault, Jr, B.J., , Perou, C.M., Boissy, R.E., Duyk, G.M., Spritz, R.A. & Moore, K.J. (1996) Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nature Genetics, 14, 307-311.
74. Nakajima, H., Park, H.L. & Henkart, P.A. (1995) Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. Journal of Experimental Medicine, 181, 1037-1046.
75. Nakajima, H., Cella, M., Bouchon, A., Grierson, H.L., Lewis, J., Duckett, C., Cohen, J.I. & Colonna, M. (2000) Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. European Journal of Immunology, 30, 3309-3318.
76. Nichols, K.E., Harkin, D.P., Levitz, S., Krainer, M., Kolquist, K.A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., Buckler, A.J., Wise, C., Ashley, J., Lovett, M., Valentine, M.B., Look, A.T., Gerld, W., Housman, D.E. & Haber, D.A. (1998) Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proceedings of the National Academy of Sciences of the United States of America, 95, 13765-13770.
77. Ohadi, M., Lalloz, M.R., Sham, P., Zhao, J., Dearlove, A.M., Shiach, C., Kinsey, S., Rhodes, M. & Layton, D.M. (1999) Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. American Journal of Human Genetics, 64, 165-171.
78. Okano, M. (2002) Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome. Critical Reviews in Oncology and Hematology, 44, 273-282.
79. Osugi, Y., Hara, J. & Tagawa, S. (1997) Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood, 89, 4100-4103.
80. Peng, S.L., Moslehi, J., Robert, M.E. & Craft, J. (1998) Perforin protects against autoimmunity in lupus-prone mice. Journal of Immunology, 160, 652-660.
81. Perry, L.L., Feilzer, K., Hughes, S. & Caldwell, H.D. (1999) Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. Infection and Immunity, 67, 1379-1385.
82. Reiner, A.P. & Spivak, J.L. (1988) Hemophagocytic histiocytosis: a report of 23 new patients and a review of the literature. Medicine, 67, 369-388.
83. Rossi, C.P., McAllister, A., Tanguy, M., Kagi, D. & Brahic, M. (1998) Theiler's virus infection of perforin-dependent mice. Journal of Virology, 72, 4515-4519.
84. Rottenberg, M.E., Rothfuchs, G., Gigliotti, D., Svanholm, C., Bandholtz, L. & Wigzell, H. (1999) Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. Journal of Immunology, 162, 2829-2836.
85. Russell, J.H. & Ley, T.J. (2002) Lymphocyte-mediated cytotoxicty. Annual Reviews of Immunology, 20, 323-370.
86. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M.G., Oettgen, H., de Vries, J.E., Aversa, G. & Terhorst, C. (1998) The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature, 395, 462-469.
87. Schooley, R.T., Carey, R.W., Miller, G., Henle, W., Eastman, R., Mark, E.J., Kenyon, K., Wheeler, E.O. & Rubin, R.H. (1986) Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Annals of Internal Medicine, 104, 636-643.
88. Shankar, P., Xu, Z. & Liberman, J. (1999) Viral-specific cytotoxic T lymphocytes lyse HIV-infected primary T lymphocytes by the granule exocytosis pathway. Blood, 94, 3084-3093.
89. Shi, L., Kraut, R.P., Aebersold, R. & Greenberg, A.H. (1992) A natural killer cell granule protein that induces DNA fragmentation and apoptosis. Journal of Experimental Medicine, 175, 553-566.
90. Shiver, J.W., Su, L. & Henkart, P.A. (1992) Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell, 71, 315-322.
91. Shustov, A., Luzina, I., Nguyen, P., Papadimitriou, J.C., Handwerger, B., Elkon, K.B. & Via, C.S. (2000) Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. Journal of Clinical Investigation, 106, R39-R47.
92. Smyth, M.J., Thia, K.Y., Street, S.E.A., MacGregor, D., Godfrey, D.I. & Trapani, J.A. (2000) Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. Journal of Experimental Medicine, 192, 755-760.
93. Spaner, D., Raju, K., Rabinovich, B. & Miller, R.G. (1999) A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice. Journal of Immunology, 162, 1192-1199.
94. Spielman, J., Leek, R.K. & Podack, E.R. (1998) Perforin/Fas-ligand double deficiency is associated with macrophage-expansion and severe pancreatitis. Journal of Immunology, 161, 7063-7070.
95. Stepp, S.E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, P.A., Henter, J.I., Bennett, M., Fischer, A., de Saint Basile, G. & Kumar, V. (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science, 286, 1957-1959.
96. Straus, S.E. (1988) The chronic mononucleosis syndrome. Journal of Infectious Diseases, 157, 405-412.
97. Street, S.E., Cretney, E. & Smyth, M.J. (2001) Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastases. Blood, 97, 192-197.
98. Suga, N., Takada, H., Nomura, A., Ohga, S., Ishii, E., Ihara, K., Ohshima, K. & Hara, T. (2002) Perforin defects of primary haemophagocytic lymphohistiocytosis in Japan. British Journal of Hematology, 116, 346-349.
99. Sullivan, K., Delaat, C.A., Douglas, S.D. & Filipovich, A.H. (1998) Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatric Research, 44, 465-468.
100. Sun, Q., Burton, R.L., Pollok, K.E., Emanuel, D.J. & Lucas, K.G. (1999) CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood. Cellular Immunology, 195, 81-88.
101. Takada, H., Ohga, S., Mizuno, Y., Suminor, A., Matsuzaki, A., Ihara, K., Kinukawa, N., Oshima, K., Kohno, K., Kurimoto, M. & Hara, T. (1999) Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. British Journal of Haematology, 106, 182-189.
102. Takada, H., Takahata, Y., Nomura, A., Ohga, S., Mizuno, Y. & Hara, T. (2003) Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis. Clinical Experimental Immunology, 133, 448-453.
103. Ueda, I., Morimoto, A., Inaba, T., Yagi, T., Hibi, S., Sugimoto, T., Sako, M., Yani, F., Fukushima, T., Nakayama, M., Ishii, E. & Imashuku, S. (2003) Characteristic peforin gene mutations of haemophagocytic lymphohistiocytosis in Japan. British Journal of Haematology, 121, 503-510.
104. Uellner, R., Zvelebil, M.J., Hopkins, J., Jones, J., MacDougall, L.K., Morgan, B.P., Podack, E., Waterfield, M.D. & Griffiths, G.M. (1997) Perform is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain. EMBO Journal, 16, 7287-7296.
105. Usherwood, E.J., Brooks, J.W., Sarawar, S.R., Cardin, R.D., Young, W.D., Allen, D.J., Doherty, P.C. & Nash, A.A. (1997) Immunological control of murine gammaherpesvirus infection is independent of perform. Journal of General Virology, 78, 2025-2030.
106. Voskoboinik, I., Thia, M-C., De Bono, A., Browne, K., Cretney, E., Jackson, J.T., Darcy, P.K., Jane, S.M., Smyth, M.J. & Trapani, J.A. (2004) The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perform (PFN1) gene. Journal of Experimental Medicine, 200, 811-816.
107. Walsh, C.M., Matloubian, M., Liu, C.C., Ueda, R., Kurahara, C.G., Christensen, J.L., Huang, M.T.F., Young, J.D.E., Ahmed, R. & Clark, W.R. (1994) Immune function in mice lacking the perform gene. Proceedings of the National Academy of Sciences of the United States of America, 91, 10854-10858.
108. Wilson, S.M., Yip, R., Swing, D.A., O'Sullivan, T.N., Zhang, Y., Novak, E.K., Swank, R.T., Russell, L.B., Copeland, N.G. & Jenkins, N.A. (2000) A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. Proceedings of the National Academy of Sciences United States of America, 97, 7933-7938.
109. Wu, C., Nguyen, K.B., Pien, G.C., Wang, N., Gullo, C., Duncan, H., Sosa, M.R., Edwards, M.J., Borrow, P., Satoskar, A.R., Sharpe, A.H., Biron, C.A. & Terhorst, C. (2001) SAP controls T cell responses to virus and terminal differentiation of T(H)2 cells. Nature Immunology, 2, 410-414.
110. Yoshimi, A., Tsuge, I., Namizaki, H., Hoshino, Y., Kimura, H., Takahashi, Y., Watanabe, N., Kuzushima, K. & Kojima, S. (2002) Epstein-Barr virus-specific T-cell cytotoxicity is mediated through the perform pathway in patients with lymphoproliferative disorders after allogeneic bone marrow transplantation. British Journal of Hematology, 116, 710-715.
111. Zhang, D., Shankar, P., Xu, Z., Harnisch, B., Chen, G., Lange, C., Lee, S.J., Valdez, H., Lederman, M.M. & Lieberman, J. (2003) Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood, 101, 226-235.
112. Zhou, P., Freidag, B.L., Caldwell, C.C. & Seder, R.A. (2001) Perforin is required for primary immunity to Histoplasma capsulatum. Journal of Immunology, 166, 1968-1974.